Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation

NCT02175589 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT02175589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02175589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation
Lead sponsor
Rambam Health Care Campus
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2014
Completion date
January 31, 2015
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

familial mediterranean fever